Vireo Growth Inc · CSE:VREO
Vireo Growth — Vireo Health — Canaccord Genuity Cannabis Conference 2019
21 slides from Vireo Growth's conference presentation, May 14, 2019
Slide 1: Canaccord Genuity Cannabis Conference
Canaccord Genuity Cannabis Conference May 14, 2019 CNSX: VREO
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This document includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, referred to herein and which constitute “forward-lo
Slide 3: Our Mission
Our Mission “We are building the cannabis company of the future by bringing the best of science, medicine and engineering to the cannabis industry.” - Kyle Kingsley, M.D. Founder & CEO Our Mission || 3
Slide 4: Corporate Timeline
Corporate Timeline July 2014 June 2015 September 2015 May 2017 August 2017 July 2018 December 2018 March 2019 Broke ground on Awarded 1 of only 5 Midwest Hemp Launched first Participation in Awarded cultivation, Awarded 3 Retail Executed RTO Minnesota vertically integrated Research harvests first ca
Slide 5: Vireo Strategy
Vireo Strategy Opportunistic Best-in-Class Real Intellectual Growth Customer Experience Property Organic Growth Through Highly Professional Industrial Scale Process Merit-Based License Wins Retail Apparatus and Equipment Cost-Effective M&A Home Delivery Novel Proprietary Activity Cannabis Formulatio
Slide 6: Vireo's Footprint
Vireo’s Footprint MN MA NY RI PA NV OH CA MD AZ Current Footprint NM Binding Purchase & Sale Agreement(1) Subject to pending transactions Hemp assets Puerto Rico (1) Vireo expects this transaction to close during the second-quarter of 2019, subject to customary conditions of closing. Vireo’s Footpri
Slide 7: State-by-State Snapshot of Operations
State-by-State Snapshot of Operations: (1) (2) Minnesota New York Pennsylvania Maryland Ohio Rhode Island Arizona Puerto Rico Nevada Massachusetts New Mexico California Population 5.6 19.9 12.8 6.0 11.7 1.1 7.0 3.7 3.1 6.9 2.1 39.8 (MM) Purchase and Status Current Current Current Current Current Cur
Slide 8: Best-in-Class Customer Experience: Retail Dispensaries
Best-in-Class Customer Experience: Best-in-Class Customer Experience: Retail Dispensaries Retail Dispensaries Green Goods™ Dispensary Concepts Launching in 2Q19 Slide content reflects layout of Bethlehem, PA location Best-in-Class FY18 Results Customer Conference Experience Call || || 8
Slide 9: Best-in-Class Customer Experience: Home Delivery & In-Store Pick-Up
Best-in-Class Customer Experience: Home Delivery & In-Store Pick-Up Best-in-Class Customer Experience || 9
Slide 10: Best in Class Customer Experience: Brands
Best In Class Customer Experience: Brands Pharmaceutical-grade High Potency Products for High-Quality, Innovative Balanced, Comfortable, Products Geared Toward a Sophisticated Consumer Products for a Curious, Reliable Products for Patients Socially-Conscious Consumer Everyday Wellness Vireo Brands |
Slide 11: Real Intellectual Property: Research Partners
Real Intellectual Property: Research Partners Exclusive agreement to study the Randomized trial of medical Study to evaluate cannabis use IRB-approved research study to use of Captisol in the development cannabis in patients with newly among older adults – how they examine older adults’ use of and c
Slide 12: Real Intellectual Property: Current Portfolio
Real Intellectual Property: Current Portfolio Short Term Monetization Long-Term Applications Cannabis Moist Snuff Composition Harm Reduction Additive for Tobacco Products Multi-Channel Vaporizer Method for Treating Non-Cannabinoid Negative Control Antidepressant Withdrawal Formulations (Placebo) Syn
Slide 13: Real Intellectual Property: Hemp
Real Intellectual Property: Hemp Vireo is focused on the multi-billion dollar hemp market opportunity by developing combine-friendly, high- cannabinoid cannabis cultivars along with innovative consumer products. Midwest Hemp 1776 Hemp Research - Minnesota – New York Licensed to Cultivate and License
Slide 14: Fiscal Year 2019 Development Plans
Fiscal Year 2019 Development Plans During fiscal year 2019, Vireo expects to: • Launch Green Goods™ dispensaries in Pennsylvania and expand its retail footprint in New Mexico • Increase cultivation and processing capacity in Arizona, Minnesota, New Mexico and New York • Begin building new facilities
Slide 15: Leadership Team
Leadership Team Kyle Kingsley, M.D. – Chief Executive Officer Amber Shimpa – Chief Financial Officer Dr. Kingsley is a board-certified emergency medicine physician, Amber has served as the Chief Financial Officer of Vireo entrepreneur, and inventor. Dr. Kingsley has a strong track Health since incep
Slide 16: Board of Directors
Board of Directors Kyle Kingsley, M.D. – Chairman, Chief Executive Officer Amber Shimpa – Chief Financial Officer Dr. Kingsley is a board-certified emergency medicine physician, Amber has served as the Chief Financial Officer of Vireo entrepreneur, and inventor. Dr. Kingsley has a strong track Healt
Slide 17: Slide 17
Slide 18: Key Fourth Quarter and FY18 Financial Metrics
Key Fourth Quarter and FY18 Financial Metrics Three Months Ended Twelve Months Ended December 31, December 31, $ in millions, except per share data 2018 2017 Variance 2018 2017 Variance Revenue $5.6 $3.3 $2.4 $18.5 $10.9 $7.6 Gross Profit (Before Fair Value Adjustments) $1.8 $0.9 $0.8 $8.9 $5.8 $3.2
Slide 19: Reconciliation of IFRS to Non-IFRS Financial Measures
Reconciliation of IFRS to Non-IFRS Financial Measures Three Months Ended Twelve Months Ended December 31, December 31, 2018 2017 2018 2017 Net income (loss) (IFRS) $ (1,182,621) $ 273,098 $ (3,077,353) $ (430,689) Transaction costs 386,882 - 448,480 - Share-based compensation 572,869 - 2,072,706 - N
Slide 20: Consolidated Statements of Loss and Comprehensive Loss
Consolidated Statements of Loss and Comprehensive Loss Vireo Health, Inc. Consolidated Statements of Loss and Comprehensive Loss For the Years Ended December 31, 2018 and 2017 (Expressed in United States Dollars) Appendix || 20
Slide 21: Consolidated Statement of Financial Position
Consolidated Statement of Financial Position Vireo Health, Inc. Consolidated Statement of Financial Position For the Years Ended December 31, 2018 and 2017 (Expressed in United States Dollars) Appendix || 21
Vireo Health — Canaccord Genuity Cannabis Conference 2019 on 6ix